Vessel dilator: most potent of the atrial natriuretic peptides in decreasing the number and DNA synthesis of human squamous lung cancer cells.

Abstract

Within 24 h four peptide hormones, i.e. vessel dilator, long acting natriuretic peptide, kaliuretic peptide, and atrial natriuretic peptide and their intracellular mediator cyclic GMP decreased the number of human squamous lung cancer cells 51, 22, 25, 21, and 30%, respectively. There was not any proliferation in the 3 days following this decrease in cell number. Vessel dilator decreased DNA synthesis 85% in the squamous lung cancer cells. Thus, vessel dilator significantly decreased the number of human squamous lung cancer cells and their DNA synthesis, mediated in part by cyclic GMP, more than other peptide hormones.

• Authors: Brian A Vesely, Shannon R Fitz, William R Gower Jr, David L Vesely
• Journal: Cancer letters (Cancer Lett) Vol. 233 Issue 2 Pg. 226-31 (Feb 28 2006) ISSN: 0304-3835 [Print] Ireland
• PMID: 15893414 (Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)

Chemical References

• DNA, Neoplasm
• Peptide Fragments
• Protein Precursors
• atrial natriuretic factor precursor (79-98)
• atrial natriuretic factor prohormone (31-67)
• Atrial Natriuretic Factor
• Cyclic GMP

Topics

• Atrial Natriuretic Factor (pharmacology)
• Carcinoma, Squamous Cell (drug therapy, metabolism, pathology)
• Cell Proliferation (drug effects)
• Cyclic GMP (pharmacology)
• DNA Replication (drug effects)
• DNA, Neoplasm (drug effects)
• Humans
• Lung Neoplasms (drug therapy, metabolism, pathology)
• Peptide Fragments (pharmacology)
• Protein Precursors (pharmacology)
• Tumor Cells, Cultured